Silexion Therapeutics Corp. (SLXN)
1.53
-0.03
(-1.92%)
USD |
NASDAQ |
Mar 18, 16:00
1.62
+0.09
(+5.88%)
After-Hours: 07:04
Silexion Therapeutics Total Liabilities (Quarterly) : 4.612M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Compugen Ltd. | 54.14M |
| Pluri, Inc. | 39.81M |
| BioLineRx Ltd. | 20.27M |
| XTL Biopharmaceuticals Ltd. | 3.115M |
| Can-Fite BioPharma Ltd. | -- |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.215M |
| Shareholders Equity (Quarterly) | 2.603M |
| Debt to Equity Ratio | 0.7822 |
| Current Ratio | 2.406 |
| Net Debt Paydown Yield | 7.58% |